Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2061]

Advances in T cell lymphoma treatment

Dr Francine Foss, Prof Pier Luigi Zinzani, Prof Bertrand Coiffier, Dr Claire Dearden

Advances in T cell lymphoma treatment ( Dr Francine Foss, Prof Pier Luigi Zinzani, Prof Bertrand Coiffier, Dr Claire Dearden )

Highlights from day one of the 5th International Workshop

Prof Gareth Morgan (Chair) - Institute of Cancer Research, Sutton, UK; Prof Keith Stewart - Mayo Clinic, Arizona, USA; Prof Kenneth Anderson - Dana-Farber Cancer Institute Boston, MA

Highlights from day one of the 5th International Workshop ( Prof Gareth Morgan (Chair) - Institute of Cancer Research, Sutton, UK; Prof Keith Stewart - Mayo Clinic, Arizona, USA; Prof Kenneth Anderson - Dana-Farber Cancer Institute Boston, MA )

Highlights from day two of the 5th International Workshop

Prof Gareth Morgan (Chair) - Institute of Cancer Research, Sutton, UK; Prof Keith Stewart - Mayo Clinic, Arizona, USA; Prof Kenneth Anderson - Dana-Farber Cancer Institute Boston, MA

Highlights from day two of the 5th International Workshop ( Prof Gareth Morgan (Chair) - Institute of Cancer Research, Sutton, UK; Prof Keith Stewart - Mayo Clinic, Arizona, USA; Prof Kenneth Anderson - Dana-Farber Cancer Institute Boston, MA )

Roundup of the EMCC 2011 conference

Prof Gordon McVie - European Institute of Oncology and ecancer

Roundup of the EMCC 2011 conference ( Prof Gordon McVie - European Institute of Oncology and ecancer )

Ruxolitinib successfully treats myelofibrosis symptoms and improves quality of life

Dr Srdan Verstovsek - The University of Texas, MD Anderson Cancer Centre, Houston

Ruxolitinib successfully treats myelofibrosis symptoms and improves quality of life ( Dr Srdan Verstovsek - The University of Texas, MD Anderson Cancer Centre, Houston )

The P-Medicine project; data sharing and integration for personalised medicine

Dr Simona Rossi - Swiss Institute for Bioinformatics, Lausanne, Switzerland

The P-Medicine project; data sharing and integration for personalised medicine ( Dr Simona Rossi - Swiss Institute for Bioinformatics, Lausanne, Switzerland )

Patient non-compliance to treatment schedules

Giora Sharf - Israeli CML Patient's Support Group

Patient non-compliance to treatment schedules ( Giora Sharf - Israeli CML Patient's Support Group )

VTD consolidation therapy for multiple myeloma

Professor Michele Cavo - Institute of Haematology & Medical Oncology Seragnoli, University of Bologna, Italy

VTD consolidation therapy for multiple myeloma ( Professor Michele Cavo - Institute of Haematology & Medical Oncology Seragnoli, University of Bologna, Italy )

Dasatinib therapy for CML patients unsuitable for imatinib

Prof Giuseppe Saglio - University of Turin, Italy

Dasatinib therapy for CML patients unsuitable for imatinib ( Prof Giuseppe Saglio - University of Turin, Italy )

Key CLL research from EHA 2011

Prof Emili Montserrat - Institute of Haematology and Oncology, Hospital Clinic, Spain

Key CLL research from EHA 2011 ( Prof Emili Montserrat - Institute of Haematology and Oncology, Hospital Clinic, Spain )

Patient advocacy session on treatment adherence

Jan Geissler - Co-founder, CML Advocates Network; Giora Sharf - Israeli CML Patient’s Support Group; Dr Lina Eliasson - Imperial College London, UK

Patient advocacy session on treatment adherence ( Jan Geissler - Co-founder, CML Advocates Network; Giora Sharf - Israeli CML Patient’s Support Group; Dr Lina Eliasson - Imperial College London, UK )

Latest advances in multiple myeloma

Prof Pieter Sonneveld - University Hospital Rotterdam, Netherlands

Latest advances in multiple myeloma ( Prof Pieter Sonneveld - University Hospital Rotterdam, Netherlands )

More from ecancer